Explore GLP-1, GIP, glucagon and multi-receptor peptide materials organized for controlled metabolic signaling research.
Collection Research Guide
The records on this page are grouped by research area, but they are not versions of the same material. Check the compound name and stated receptor scope before comparing strengths, formats or analytical documents.
Semaglutide is listed as a GLP-1 record. Tirzepatide is listed with GIP and GLP-1 terminology, while Retatrutide is listed with GIP, GLP-1 and glucagon terminology. Cagrilintide is an adjacent amylin-related record, and CagriSema is a multi-component blend. Sharing a category does not make these materials equivalent.
The compound name identifies the material; the milligram value identifies an available strength. A higher number does not turn one compound into another or make two records directly comparable. Multiple strengths of the same named material remain on one product page so the name, specifications and variants can be checked together.
A purity percentage is useful only when it belongs to the material and lot being reviewed. Check the product name, batch or lot number and report date first. Then identify the stated test method and result. If the batch on the report does not match the listed lot, treat it as a different record.
Quick review order: compound name → receptor scope → available strength → batch number → report date → test method → reported result.
